437985-07-4

Upstream product

• 437985-04-1 (S)-2-{[(S)-1-[(S)-1-((R)-1-Aminomethyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethylcarbamoyl]-2-(1H-indol-3-yl)-ethylcarbamoyl]-methyl}-succinic acid 4-tert-butyl ester 
• 264144-30-1 3(S)-benzyloxycarbonylpentanedioic acid mono-tert-butyl ester 
• 211689-64-4 (2-(R)-{2-(S)-[2-(S)-amino-3-(1H-indol-3-yl)propionylamino]-3-phenylpropionylamino}-3-phenylpropyl)carbamic acid benzyl ester 
• 211689-63-3 (2-{2-[2-tert-butoxycarbonylamino-3-(1H-indol-3-yl)-propionylamino]-3-phenyl-propionylamino}-3-phenyl-propyl)-carbamic acid benzyl ester 

Relevant academic research and scientific papers

Insertion of 2-carboxysuccinate and tricarballylic acid fragments into cyclic-pseudopeptides: New antagonists for the human tachykinin NK-2 receptor

A series of cylic pseudopeptides were the synthesized containing the sequence -Trp-Phe-(D)PheΨCH2NH-, the terminal ends of which were bound to 2-carboxy succinate or enantiomerically enriched tricarballylic acid to give the final cyclic structu